Integra Lifesciences News

Integra Lifesciences: Strategic Manufacturing Shifts Amid Supply Constraints – A Hold Rating Perspective

TipRanksJul 16 08:40 ET

Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating

MT NewswiresJul 16 07:08 ET

Integra Lifesciences Sell Rating Justified by Production Delays and Overvalued Stock

TipRanksJul 16 06:27 ET

Integra Lifesciences Analyst Ratings

BenzingaJul 15 13:04 ET

Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating

MT NewswiresJul 15 07:05 ET

Integra Lifesciences: Hold Rating Justified by Operational Struggles and Competitive Underperformance

TipRanksJul 13 11:33 ET

Integra Lifesciences Analyst Ratings

BenzingaJul 10 21:10 ET

Integra Lifesciences Analyst Ratings

BenzingaMay 22 13:37 ET

Oppenheimer Cuts Integra to Perform, Cites Boston Plant Delays

Seeking AlphaMay 7 10:20 ET

Wells Fargo Downgrades Integra Lifesciences to Equal-Weight, Lowers Price Target to $25

BenzingaMay 7 08:44 ET

Integra Lifesciences (IART) Was Downgraded to a Hold Rating at Oppenheimer

TipRanksMay 7 08:37 ET

Integra Lifesciences Analyst Ratings

BenzingaMay 7 07:37 ET

Integra Lifesciences Sell Rating Justified Amid Operational Delays and Market Skepticism

TipRanksMay 7 05:21 ET

Integra Lifesciences: Hold Rating Amidst Facility Delays and Operational Uncertainties

TipRanksMay 6 16:30 ET

Buy Rating for Integra Lifesciences Amid Favorable Medicare Policy Changes

TipRanksApr 26 05:25 ET

Jefferies Sticks to Their Buy Rating for Integra Lifesciences (IART)

TipRanksApr 22 09:30 ET

Integra Lifesciences Analyst Ratings

BenzingaApr 3 11:31 ET

Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target Is $38

MT NewswiresApr 3 08:42 ET

Integra Lifesciences Analyst Ratings

BenzingaFeb 29 14:21 ET

BTIG Sticks to Its Hold Rating for Integra Lifesciences (IART)

TipRanksFeb 29 06:52 ET